| Product Code: ETC7548791 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Neuroblastoma Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Neuroblastoma Market Revenues & Volume, 2021 & 2031F |
3.3 India Neuroblastoma Market - Industry Life Cycle |
3.4 India Neuroblastoma Market - Porter's Five Forces |
3.5 India Neuroblastoma Market Revenues & Volume Share, By Diagnostics, 2021 & 2031F |
3.6 India Neuroblastoma Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 India Neuroblastoma Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 India Neuroblastoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about neuroblastoma among healthcare professionals and the general public in India |
4.2.2 Technological advancements in diagnostic tools and treatment options for neuroblastoma |
4.2.3 Growing investments in healthcare infrastructure and research and development activities related to neuroblastoma in India |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities and expertise for diagnosing and treating neuroblastoma in remote areas of India |
4.3.2 High treatment costs and lack of adequate health insurance coverage for neuroblastoma patients in India |
5 India Neuroblastoma Market Trends |
6 India Neuroblastoma Market, By Types |
6.1 India Neuroblastoma Market, By Diagnostics |
6.1.1 Overview and Analysis |
6.1.2 India Neuroblastoma Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.3 India Neuroblastoma Market Revenues & Volume, By MIBG scan, 2021- 2031F |
6.1.4 India Neuroblastoma Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.5 India Neuroblastoma Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.2 India Neuroblastoma Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 India Neuroblastoma Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.3 India Neuroblastoma Market Revenues & Volume, By Medications, 2021- 2031F |
6.2.4 India Neuroblastoma Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.5 India Neuroblastoma Market Revenues & Volume, By Radiation therapy, 2021- 2031F |
6.2.6 India Neuroblastoma Market Revenues & Volume, By Stem cell transplant, 2021- 2031F |
6.2.7 India Neuroblastoma Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.3 India Neuroblastoma Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 India Neuroblastoma Market Revenues & Volume, By Hospitals and clinics, 2021- 2031F |
6.3.3 India Neuroblastoma Market Revenues & Volume, By Ambulatory surgical centers, 2021- 2031F |
6.3.4 India Neuroblastoma Market Revenues & Volume, By Diagnostic centers, 2021- 2031F |
6.3.5 India Neuroblastoma Market Revenues & Volume, By Research centers, 2021- 2031F |
6.3.6 India Neuroblastoma Market Revenues & Volume, By Others, 2021- 2031F |
7 India Neuroblastoma Market Import-Export Trade Statistics |
7.1 India Neuroblastoma Market Export to Major Countries |
7.2 India Neuroblastoma Market Imports from Major Countries |
8 India Neuroblastoma Market Key Performance Indicators |
8.1 Number of research studies and clinical trials conducted in India related to neuroblastoma |
8.2 Adoption rate of advanced diagnostic tools and treatment modalities for neuroblastoma in Indian healthcare facilities |
8.3 Survival rates and quality of life outcomes for neuroblastoma patients in India |
9 India Neuroblastoma Market - Opportunity Assessment |
9.1 India Neuroblastoma Market Opportunity Assessment, By Diagnostics, 2021 & 2031F |
9.2 India Neuroblastoma Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 India Neuroblastoma Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 India Neuroblastoma Market - Competitive Landscape |
10.1 India Neuroblastoma Market Revenue Share, By Companies, 2024 |
10.2 India Neuroblastoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here